Mr. Matthew Mackowski serves as Chairman & Managing Director at Telegraph Hill Partners. He served as a Board Member at Conductiv, Asuragen and Teknova. He has served on Althea Technologies' Board since 2006. He served as Board Member at TrakCel. He has been a healthcare-focused venture capital investor since 1980. He began his venture capital career with Citicorp Venture Capital, where he was VP and a member of the investment executive committee. Mr. Mackowski later joined Robertson, Stephens and Co. and was partner and Chairman of the Venture Capital Group. In 1991 he formed Mackowski and Shepler, an investment partnership focused on developing life science and medical technology companies and the predecessor to Telegraph Hill Partners (THP) where he serves as Chairman and Managing Director. He received a B.A. from Duke University and an MBA from The Wharton School.